Replimune Ltd

Replimune Limited develops biotechnology solutions focused on cancer treatment. The company engineers proprietary HSV-1 based therapies with immune activating transgenes and conducts clinical trials for investigational oncolytic immunotherapies in solid tumors. Replimune Ltd serves cancer patients, especially those with difficult-to-treat solid tumors, in the UK and US.